We have identified a lipo-protein complex with growth-promoting properties in supernates of human lymphoblastoid cell lines and activated normal B cells. The protein moiety is prealbumin which originates from the culture medium. Prealbumin (P) combines with a novel lipid factor (LF) that is synthesized and released by B cells to form LFP. According to mass spectrometric analysis, LF occurs in at least three forms. All contain long-chain, unsaturated fatty acids. The possible elemental composition of one LF form is C22 H43 ON. B cell produced LFP was discovered due to its ability to increase proliferation of B cells at low density which qualifies the lipid as an autocrine growth factor. A second broader range of effects has been identified in preliminary experiments. We propose a comprehensive study of the biochemistry, biology and immunobiology of LFP. We will isolate and analyze the different forms of LF by gas chromatography/mass spectrometry, NMR and IR (expecting to find different fatty acid moieties in a common derivative, such as perhaps a fatty acid amide), and we will attempt to synthesize LF. Using the synthetic LF preferentially, we will determine the physical properties of LFP and possible other LF-carrier complexes, will determine the physiology of LFP for normal and cloned B and T cells. We will begin the analysis of the role of LFP in the immune response, focusing on its place in the lymphokine cascade. Supported by evidence that lymphoma cell lines release as well as respond to LFP, we also propose to determine the significance of LFP in malignancy. Finally, we will perform studies on the mechanism of LFP action, beginning with LFP binding to a cellular receptor and the intracellular fate of LF.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA049933-04
Application #
3194286
Study Section
Immunobiology Study Section (IMB)
Project Start
1989-07-24
Project End
1994-04-30
Budget Start
1992-05-01
Budget End
1993-04-30
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Hoyos, Beatrice; Jiang, Sulin; Hammerling, Ulrich (2005) Location and functional significance of retinol-binding sites on the serine/threonine kinase, c-Raf. J Biol Chem 280:6872-8
Korichneva, Irina; Hoyos, Beatrice; Chua, Ramon et al. (2002) Zinc release from protein kinase C as the common event during activation by lipid second messenger or reactive oxygen. J Biol Chem 277:44327-31
Hoyos, Beatrice; Imam, Asiya; Korichneva, Irina et al. (2002) Activation of c-Raf kinase by ultraviolet light. Regulation by retinoids. J Biol Chem 277:23949-57
Hoyos, B; Imam, A; Chua, R et al. (2000) The cysteine-rich regions of the regulatory domains of Raf and protein kinase C as retinoid receptors. J Exp Med 192:835-45
Liu, C; Calogero, A; Ragona, G et al. (1996) EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this sup Crit Rev Oncog 7:101-25
Derguini, F; Nakanishi, K; Hammerling, U et al. (1994) Intracellular signaling activity of synthetic (14R)-, (14S)-, and (14RS)-14-hydroxy-4,14-retro-retinol. Biochemistry 33:623-8
Buck, J; Grun, F; Derguini, F et al. (1993) Anhydroretinol: a naturally occurring inhibitor of lymphocyte physiology. J Exp Med 178:675-80
Eppinger, T M; Buck, J; Hammerling, U (1993) Growth control or terminal differentiation: endogenous production and differential activities of vitamin A metabolites in HL-60 cells. J Exp Med 178:1995-2005
Garbe, A; Buck, J; Hammerling, U (1992) Retinoids are important cofactors in T cell activation. J Exp Med 176:109-17
Buck, J; Derguini, F; Levi, E et al. (1991) Intracellular signaling by 14-hydroxy-4,14-retro-retinol. Science 254:1654-6

Showing the most recent 10 out of 12 publications